Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...

Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Tivozanib plus nivolumab had similar patient-reported outcomes to tivozanib alone in advanced kidney cancer after prior ...

Ife, Osun State, Oluwafemi Ayo-Owolawi, has died months after Nigerians raised N9.4m to help him through a protracted battle with renal cancer.

Nigerian medical experts and specialist hospitals are making significant strides in kidney treatment and transplants.

Adding cabozantinib to first-line treatment with nivolumab and ipilimumab improved PFS — but not OS — in patients with RCC.

The first month of 2025 was an interesting one, with inflation rising faster than expected, giving another motivation for the Federal Reserve to keep interest rates unchanged.

New results uphold previous findings regarding the efficacy of cabozantinib, nivolumab, and ipilumumab arm for advanced renal ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Poster Session C: Renal Cell Cancer; ...

Dr. Bergerot concluded her presentation discussing the development of FKSI-23, a new bespoke health-related quality of life questionnaire for the advanced and adjuvant setting in RCC with the ...

The Coordinating Minister for Health and Social Welfare, Prof. Muhammadu Ali Pate, has expressed the assurance that Nigeria will overcome the United States President Donald Trump's sweeping health ...